Zai Lab Limited today announced that the 2024 National Reimbursement Drug List (NRDL) released by China's National Healthcare Security Administration (NHSA) has been updated to include the following ...
SINTBILO® (tafolecimab injection), developed independently by Innovent, is a fully human lgG2 monoclonal antibody that can specifically bind to PCSK9, reducing LDL-C levels by inhibiting ...
Research collaboration by the Texas A&M Department of Entomology and the U.S. Department of Agriculture, USDA, creates potential for genetic tools to control disease-spreading ticks.